Theralase Technologies Inc.
TLT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.11M | -3.18M | -3.25M | -3.29M | -3.39M |
| Total Depreciation and Amortization | 198.70K | 202.50K | 206.00K | 210.20K | 212.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 404.50K | 373.00K | 410.30K | 465.00K | 480.20K |
| Change in Net Operating Assets | 69.80K | -419.60K | 171.70K | -395.00K | -320.00K |
| Cash from Operations | -2.44M | -3.03M | -2.47M | -3.01M | -3.02M |
| Capital Expenditure | -14.50K | -18.00K | -19.80K | -21.50K | -27.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.50K | -18.00K | -19.80K | -21.50K | -27.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -117.10K | -121.80K | -120.20K | -118.70K | -117.20K |
| Issuance of Common Stock | 3.69M | 4.36M | 3.51M | 3.95M | 2.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00K | 0.00 | 0.00 | 0.00 | -800.00 |
| Cash from Financing | 2.62M | 3.11M | 2.50M | 2.84M | 1.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 165.80K | 68.70K | 12.80K | -185.80K | -1.08M |
